ALPHA-1-ACID Glycoprotein Serum, Anti-Hu

FDA 510(k) K781023 · Icl Scientific

Substantially Equivalent

510(k) numberK781023

Submission

Device name
ALPHA-1-ACID Glycoprotein Serum, Anti-Hu
Applicant
Icl Scientific
Mchenry, IL, US
Received
June 19, 1978
Decision date
August 14, 1978
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
DEX – Alpha-1-B-Glycoprotein, Antigen, Antiserum, Control
Device class
Class I (low risk)
Regulation
21 CFR 866.5420
Specialty
Immunology

Other 510(k)s with product code DEX

510(k)DeviceApplicantDecision
K823765Anti Sera to Human OroscomucoidDEX · Traditional Kent Laboratories, Inc.12/30/1982SE
K801909Lsa 290 Assay Reagents/NephelometricDEX · Traditional J.T. Baker Chemical Co.09/26/1980SE
K791341Human Alpha, Acid GlycoproteinDEX · Traditional Beckman Instruments, Inc.08/16/1979SE
K760143Serum, ALPHA-1-GLYCOPROTEIN Anti-HumanDEX · Traditional Oxford Laboratories, Inc.07/20/1976SE

More from Oxford Laboratories, Inc.

510(k)DeviceDecision
K883942Hycor Sentry Drugs of Abuse Urine ControlJJY · Traditional 11/10/1988SE
K843565Kova Trol I,Ii, III Human Urine-DriedJJW · Traditional 10/05/1984SE
K833761Therapeutic Drug ControlDKB · Traditional 01/13/1984SE
K832823Enzymune-Test TSHJLW · Traditional 10/14/1983SE
K831383Event-Test SlideJHJ · Traditional 06/22/1983SE
K823199Enzyme-Test DigoxinKXT · Traditional 11/29/1982SE
K822777Therapeutic Drug ControlDIF · Traditional 10/08/1982SE
K822346Histimune Enzyme-Ana TestLJM · Traditional 10/08/1982SE
K822465Enzymune System IJJE · Traditional 09/14/1982SE
K821374Enzymune-Test InsulinCFP · Traditional 05/28/1982SE

Questions and answers

When was ALPHA-1-ACID Glycoprotein Serum, Anti-Hu cleared by the FDA?

ALPHA-1-ACID Glycoprotein Serum, Anti-Hu (K781023) received a 510(k) decision of Substantially Equivalent on August 14, 1978, 56 days after the submission was received.

What is the product code of K781023?

The FDA product code is DEX – Alpha-1-B-Glycoprotein, Antigen, Antiserum, Control, a Class I (low risk) device regulated under 21 CFR 866.5420.